FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2069367036> ?p ?o ?g. }

• W2069367036 endingPage "134" @default.
• W2069367036 startingPage "129" @default.
• W2069367036 abstract "Elongation factor-2 kinase (eEF-2 kinase, also known as calmodulin-dependent protein kinase III), is a unique calcium/calmodulin-dependent enzyme that inhibits protein synthesis by phosphorylating and inactivating elongation factor-2 (eEF-2). We previously reported that expression/activity of eEF-2 kinase was up-regulated in several types of malignancies including Gliomas, and was associated with response of tumor cells to certain therapeutic stress. In the current study, we sought to determine whether eEF-2 kinase expression affected sensitivity of glioma cells to treatment with tumor the necrosis factor-related apoptosis-inducing ligand (TRAIL), a targeted therapy able to induce apoptosis in cancer cells but causes no toxicity in most normal cells. We found that inhibition of eEF-2 kinase by RNA interference (RNAi) or by a pharmacological inhibitor (NH125) enhanced TRAIL-induced apoptosis in the human glioma cells, as evidenced by an increase in apoptosis in the tumor cells treated with eEF-2 kinase siRNA or the eEF-2 kinase inhibitor. We further demonstrated that sensitization of tumor cells to TRAIL was accompanied by a down-regulation of the anti-apoptotic protein, Bcl-xL, and that overexpression of Bcl-xL could abrogate the sensitizing effect of inhibiting eEF-2 kinase on TRAIL. The results of this study may help devise a new therapeutic strategy for enhancing the efficacy of TRAIL against malignant glioma by targeting eEF-2 kinase." @default.
• W2069367036 created "2016-06-24" @default.
• W2069367036 creator A5001556956 @default.
• W2069367036 creator A5009075816 @default.
• W2069367036 creator A5025430347 @default.
• W2069367036 creator A5044956525 @default.
• W2069367036 creator A5054852387 @default.
• W2069367036 creator A5066716873 @default.
• W2069367036 creator A5072349186 @default.
• W2069367036 creator A5076066661 @default.
• W2069367036 creator A5078674610 @default.
• W2069367036 date "2011-10-01" @default.
• W2069367036 modified "2023-10-11" @default.
• W2069367036 title "Inhibition of eEF-2 kinase sensitizes human glioma cells to TRAIL and down-regulates Bcl-xL expression" @default.
• W2069367036 cites W1971405891 @default.
• W2069367036 cites W1974649594 @default.
• W2069367036 cites W1979995768 @default.
• W2069367036 cites W2011326217 @default.
• W2069367036 cites W2039973219 @default.
• W2069367036 cites W2045629309 @default.
• W2069367036 cites W2048754817 @default.
• W2069367036 cites W2053271344 @default.
• W2069367036 cites W2062294757 @default.
• W2069367036 cites W2081479137 @default.
• W2069367036 cites W2087877138 @default.
• W2069367036 cites W2094570524 @default.
• W2069367036 cites W2109097295 @default.
• W2069367036 cites W2114714381 @default.
• W2069367036 cites W2136103100 @default.
• W2069367036 cites W2136293604 @default.
• W2069367036 cites W2137493244 @default.
• W2069367036 cites W2148976095 @default.
• W2069367036 cites W2159600136 @default.
• W2069367036 cites W2320870975 @default.
• W2069367036 doi "https://doi.org/10.1016/j.bbrc.2011.09.038" @default.
• W2069367036 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3210449" @default.
• W2069367036 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/21945617" @default.
• W2069367036 hasPublicationYear "2011" @default.
• W2069367036 type Work @default.
• W2069367036 sameAs 2069367036 @default.
• W2069367036 citedByCount "34" @default.
• W2069367036 countsByYear W20693670362012 @default.
• W2069367036 countsByYear W20693670362013 @default.
• W2069367036 countsByYear W20693670362014 @default.
• W2069367036 countsByYear W20693670362015 @default.
• W2069367036 countsByYear W20693670362016 @default.
• W2069367036 countsByYear W20693670362017 @default.
• W2069367036 countsByYear W20693670362018 @default.
• W2069367036 countsByYear W20693670362019 @default.
• W2069367036 countsByYear W20693670362020 @default.
• W2069367036 countsByYear W20693670362021 @default.
• W2069367036 countsByYear W20693670362022 @default.
• W2069367036 countsByYear W20693670362023 @default.
• W2069367036 crossrefType "journal-article" @default.
• W2069367036 hasAuthorship W2069367036A5001556956 @default.
• W2069367036 hasAuthorship W2069367036A5009075816 @default.
• W2069367036 hasAuthorship W2069367036A5025430347 @default.
• W2069367036 hasAuthorship W2069367036A5044956525 @default.
• W2069367036 hasAuthorship W2069367036A5054852387 @default.
• W2069367036 hasAuthorship W2069367036A5066716873 @default.
• W2069367036 hasAuthorship W2069367036A5072349186 @default.
• W2069367036 hasAuthorship W2069367036A5076066661 @default.
• W2069367036 hasAuthorship W2069367036A5078674610 @default.
• W2069367036 hasBestOaLocation W20693670362 @default.
• W2069367036 hasConcept C104317684 @default.
• W2069367036 hasConcept C124160383 @default.
• W2069367036 hasConcept C153911025 @default.
• W2069367036 hasConcept C161238802 @default.
• W2069367036 hasConcept C166703698 @default.
• W2069367036 hasConcept C184235292 @default.
• W2069367036 hasConcept C190283241 @default.
• W2069367036 hasConcept C22615655 @default.
• W2069367036 hasConcept C2778227246 @default.
• W2069367036 hasConcept C502942594 @default.
• W2069367036 hasConcept C54009773 @default.
• W2069367036 hasConcept C54355233 @default.
• W2069367036 hasConcept C55493867 @default.
• W2069367036 hasConcept C59143045 @default.
• W2069367036 hasConcept C67705224 @default.
• W2069367036 hasConcept C81885089 @default.
• W2069367036 hasConcept C82495950 @default.
• W2069367036 hasConcept C86803240 @default.
• W2069367036 hasConcept C95444343 @default.
• W2069367036 hasConcept C97029542 @default.
• W2069367036 hasConceptScore W2069367036C104317684 @default.
• W2069367036 hasConceptScore W2069367036C124160383 @default.
• W2069367036 hasConceptScore W2069367036C153911025 @default.
• W2069367036 hasConceptScore W2069367036C161238802 @default.
• W2069367036 hasConceptScore W2069367036C166703698 @default.
• W2069367036 hasConceptScore W2069367036C184235292 @default.
• W2069367036 hasConceptScore W2069367036C190283241 @default.
• W2069367036 hasConceptScore W2069367036C22615655 @default.
• W2069367036 hasConceptScore W2069367036C2778227246 @default.
• W2069367036 hasConceptScore W2069367036C502942594 @default.
• W2069367036 hasConceptScore W2069367036C54009773 @default.
• W2069367036 hasConceptScore W2069367036C54355233 @default.
• W2069367036 hasConceptScore W2069367036C55493867 @default.
• W2069367036 hasConceptScore W2069367036C59143045 @default.

• next